The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades.

Visit Brain Waves

CDER Neurotech Drug Reviewers Up 15 to 91

Posted on June 10, 2008

The Center for Drugs Evaluation and Research is about halfway through its planned hire of 663 employees this year, and a significant portion of the new employees are division-level medical reviewers in the Office of New Drugs. So far the Division of Neurology Products has hired 8 new team members for a total of 51 while the Division of Psychiatric Products has added 7 for a total of 40. This is important progress as CDER currently fighting a wave of attrition, as long-time FDA employees leave the agency, either for retirement or for more lucrative jobs in industry and academia.View a division-...

Original article link